Engineers Gate Manager’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22M | Sell |
60,959
-2,456
| -4% | -$89.3K | 0.03% | 687 |
|
|
2025
Q1 | $2.3M | Buy |
63,415
+28,161
| +80% | +$1.02M | 0.04% | 635 |
|
|
2024
Q4 | $1.48M | Buy |
35,254
+23,679
| +205% | +$996K | 0.03% | 777 |
|
|
2024
Q3 | $643K | Sell |
11,575
-2,789
| -19% | -$155K | 0.01% | 1261 |
|
|
2024
Q2 | $590K | Sell |
14,364
-65,505
| -82% | -$2.69M | 0.01% | 1147 |
|
|
2024
Q1 | $3.73M | Buy |
79,869
+70,917
| +792% | +$3.31M | 0.1% | 273 |
|
|
2023
Q4 | $428K | Sell |
8,952
-8,604
| -49% | -$411K | 0.01% | 1262 |
|
|
2023
Q3 | $626K | Sell |
17,556
-15,370
| -47% | -$548K | 0.02% | 953 |
|
|
2023
Q2 | $1.52M | Buy |
32,926
+16,853
| +105% | +$777K | 0.06% | 471 |
|
|
2023
Q1 | $645K | Buy |
+16,073
| New | +$645K | 0.03% | 849 |
|
|
2022
Q4 | – | Sell |
-35,788
| Closed | -$1.48M | – | 1971 |
|
|
2022
Q3 | $1.48M | Buy |
+35,788
| New | +$1.48M | 0.09% | 275 |
|
|
2021
Q3 | – | Sell |
-21,316
| Closed | -$2.03M | – | 1918 |
|
|
2021
Q2 | $2.03M | Buy |
+21,316
| New | +$2.03M | 0.13% | 177 |
|
|
2021
Q1 | – | Sell |
-10,677
| Closed | -$1.48M | – | 2073 |
|
|
2020
Q4 | $1.48M | Buy |
+10,677
| New | +$1.48M | 0.06% | 433 |
|